Scientific Library of Tomsk State University

   E-catalog        

Normal view MARC view

Managing Gout in Primary Care electronic resource by Fernando Perez-Ruiz, Ana Maria Herrero-Beites.

By: Perez-Ruiz, Fernando [author.]Contributor(s): Herrero-Beites, Ana Maria [author.] | SpringerLink (Online service)Material type: TextTextPublication details: Tarporley : Springer Healthcare Ltd. : Imprint: Springer Healthcare, 2014Description: XI, 69 p. 20 illus., 18 illus. in color. online resourceContent type: text Media type: computer Carrier type: online resourceISBN: 9781907673672Subject(s): medicine | Orthopedics | Rheumatology | Medicine & Public Health | Rheumatology | Pharmacotherapy | OrthopedicsDDC classification: 616.723 LOC classification: RC927-927.5Online resources: Click here to access online
Contents:
Disease Overview -- Physiopathology of Gout -- Diagnosis of Gout -- Treatment of Hyperuricemia in Gout -- Prevention and Treatment of Inflammation in Gout -- Appendix.
In: Springer eBooksSummary: This handbook discusses developments and the future of gout treatment, which looks promising. Gout has been a well-known disease for over 2000 years, and is the most common cause of joint inflammation in adult males. It has become apparent that no therapeutic target based on hyperuricemia outcome had been defined. Very few controlled trials were available to test the efficacy and safety of treatments, and no research on diagnosis and management had been done despite data showing that patients with gout were generally improperly treated even in the hands of specialists. In the last 10 years, good-quality evidence on gout impact and management has grown exponentially, renal transporters have been recently identified, and a number of new drugs have been approved or are under current development.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Disease Overview -- Physiopathology of Gout -- Diagnosis of Gout -- Treatment of Hyperuricemia in Gout -- Prevention and Treatment of Inflammation in Gout -- Appendix.

This handbook discusses developments and the future of gout treatment, which looks promising. Gout has been a well-known disease for over 2000 years, and is the most common cause of joint inflammation in adult males. It has become apparent that no therapeutic target based on hyperuricemia outcome had been defined. Very few controlled trials were available to test the efficacy and safety of treatments, and no research on diagnosis and management had been done despite data showing that patients with gout were generally improperly treated even in the hands of specialists. In the last 10 years, good-quality evidence on gout impact and management has grown exponentially, renal transporters have been recently identified, and a number of new drugs have been approved or are under current development.

There are no comments on this title.

to post a comment.
Share